Quantitative multiplex degenerate PCR for human endogenous retrovirus expression profiling.

Area of Science:

• Molecular Biology
• Oncology
• Virology

Background:

• Human endogenous retroviruses (HERV) expression is linked to cellular differentiation and transformation.
• Quantitative analysis of HERV transcription is a promising avenue for cancer diagnostics.
• Existing methods for HERV quantification are often qualitative or limited in scope.

Purpose of the Study:

• To develop a quantitative assay for simultaneous detection and quantification of multiple HERV families.
• To improve upon existing qualitative pan-retrovirus amplification methods.
• To establish a robust protocol for HERV expression analysis.

Main Methods:

• Development of a quantitative assay combining multiplex degenerate PCR (MD-PCR) and a colorimetric Oligo Sorbent Array (OLISA).
• Optimization of primer mix composition, including primer degeneracy and concentration, for accurate amplification.
• Independent and specific detection and quantification of nine HERV families using an OLISA microarray.

Main Results:

• The MD-PCR/OLISA method allows for precise quantification of multiple HERV families simultaneously.
• This approach offers significant improvements over qualitative pan-retrovirus amplification techniques.
• The assay provides a more comprehensive analysis compared to single-family quantitative RT-PCR.

Conclusions:

• The developed MD-PCR/OLISA assay is a powerful tool for quantitative HERV expression analysis.
• This method holds potential for advancing cancer diagnosis through HERV transcription profiling.
• The protocol provides general guidelines for designing MD-PCR applications, with a 2-day completion time after primer optimization.